Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American Tower Corp (AMT) vs Cigna Corp (CI) Price & Performance

American Tower Corp
Cigna Corp

Price performance

Price movement over the last 24 hours

Key statistics

American Tower Corp vs Cigna Corp — how do they compare? American Tower Corp trades at $169.78 (market cap $78.54B), while Cigna Corp trades at $292.51 (market cap $77.63B). The key difference: American Tower Corp and Cigna Corp are close in size by market cap, and American Tower Corp pays the higher dividend (4.14%). Which is the better fit depends on your goals.

AMTCI
Market Cap
$78.54B$77.63B
Sector
Real EstateHealth
52-Week High
$232.35$311.00
52-Week Low
$162.11$244.41
Enterprise Value
$122.07B$100.73B
Dividend Yield
4.14%2.13%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American Tower Corp

American Tower (AMT) trades at $168.59, up 2.18% today, with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals including a 26.81% net margin and 82.19% ROE. Recent news highlights its data center growth and sustainability initiatives, while analyst consensus remains strongly bullish with a $214.10 price target.

AMT presents a compelling long-term investment opportunity given its high profitability, dividend yield, and market leadership, though elevated debt levels and near-term technical weakness pose risks. Upside potential exists if the company continues executing on 5G and data center expansion, but investors should monitor interest rate sensitivity and competitive pressures.

Cigna Corp

Cigna (CI) trades at $293.46, up 0.57% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.44 and P/S of 0.28. Recent news highlights strategic initiatives, including AI integration in pharmacy services. The current price is near the consensus price target of $339.82, indicating potential upside.

The outlook for CI is positive, driven by earnings momentum, a favorable analyst consensus, and strategic growth investments. Key risks include regulatory challenges, as seen in a recent lawsuit in Tennessee, and competitive pressures in the healthcare sector. Net cash flow turned negative in 2025, which warrants monitoring. The stock presents a value opportunity with a solid dividend, but investors should weigh execution risks against growth potential.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About American Tower Corp

American Tower owns and operates more than 220,000 cell towers throughout the U.S., Asia, Latin America, Europe, and Africa. It also owns and/or operates 25 data centers in eight U.S. markets after acquiring CoreSite. On its towers, the company has a very concentrated customer base, with most revenue in each market being generated by just the top few mobile carriers. The company operates more than 40,000 towers in the U.S., which accounted for more than half of its total revenue in 2021. Outside the U.S., American Tower's greatest presence is in India and Brazil, where it operates roughly 75,000 and 19,000 towers, respectively. American Tower operates as a real estate investment trust.

Read more on AMT

About Cigna Corp

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.

Read more on CI